Screener
BridgeBio Pharma BBIO Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: BridgeBio Pharma’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001743881-26-000019
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Redeemable convertible noncontrolling interests | (951) | (570) |
| Stockholders’ deficit: | ||
| Undesignated preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 500,000,000 shares authorized; 204,386,699 shares issued and 195,707,702 shares outstanding as of March 31, 2026; 202,369,129 shares issued and 194,771,957 shares outstanding as of December 31, 2025 | 204 | 202 |
| Treasury stock, at cost; 8,678,997 shares as of March 31, 2026; 7,597,172 shares as of December 31, 2025 | (405,776) | (323,276) |
| Additional paid-in capital | 2,112,454 | 2,057,646 |
| Accumulated other comprehensive income (loss) | (8) | 12 |
| Accumulated deficit | (3,985,237) | (3,821,194) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is BridgeBio Pharma's common stock?
- BridgeBio Pharma (BBIO) reported common stock of 500M in Q1 2026.
- How has BridgeBio Pharma's common stock changed year-over-year?
- BridgeBio Pharma's common stock increased by 253707.1% year-over-year, from 197K to 500M.
- What is the long-term trend for BridgeBio Pharma's common stock?
- Over 5 years (2020 to 2025), BridgeBio Pharma's common stock has grown at a 425.3% compound annual growth rate (CAGR), from 125K to 500M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about BridgeBio Pharma's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude